Reini Juhani Hurme
Chief Executive Officer at Zora Biosciences Oy
Reini Juhani Hurme active positions
| Companies | Position | Start | End |
|---|---|---|---|
Zora Biosciences Oy
 Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Chief Executive Officer | 13/12/2006 | - |
| Founder | 13/12/2006 | - |
Career history of Reini Juhani Hurme
Former positions of Reini Juhani Hurme
| Companies | Position | Start | End |
|---|---|---|---|
| Schering Oy | Corporate Officer/Principal | - | - |
Leiras Oy
 Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Corporate Officer/Principal | - | - |
Statistics
International
| Finland | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Health Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Zora Biosciences Oy
Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Health Services |
Leiras Oy
Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Health Technology |
| Schering Oy |
- Stock Market
- Insiders
- Reini Juhani Hurme
- Experience
